Navigation Links
Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C

es with PEGINTRON will be presented at EASL evaluating patient response to therapy at certain treatment milestones, an approach that is aimed at individualising treatment for patients.

Schering-Plough also is exploring novel therapeutic approaches with PEGINTRON in combination with investigational antiviral agents to optimize treatment for patients with more difficult-to-treat forms of the disease, such as those with HCV genotype 1 and nonresponders to previous therapy.

Schering-Plough is undertaking a large, fully integrated clinical development program for its oral HCV protease inhibitor boceprevir (SCH 503034), with the goal of developing new strategies for improving treatment outcomes for patients with hepatitis C.

As part of this effort, Schering-Plough has collaborated with Wyeth/ViroPharma and Idenix/Novartis to conduct separate in vitro studies of boceprevir in combination with their respective investigational HCV polymerase inhibitors, HCV-796, a non-nucleoside polymerase inhibitor, and NM107 (the active moiety of NM283, valopicitabine), a nucleoside polymerase inhibitor. These in vitro experiments suggest that the combination of boceprevir and either one of these polymerase inhibitors achieves additive antiviral activity and a complementary resistance profile; the combination of two agents increases the barrier for developing resistance to either drug alone.

In addition, Schering-Plough has initiated the HCV SPRINT-1 study (HCV Serine Protease Inhibitor Therapy-1), a large Phase II study that is currently enrolling 400 HCV genotype 1, treatment-naïve patients in sites across the United States, Canada and Europe. The primary objective of the study is to evaluate the safety and efficacy of boceprevir 800 mg TID in combination with PEGINTRON and REBETOL in the treatment-naïve patient population.

Schering-Plough also is conducting a large Phase II study evaluating the safety and efficacy of boceprevi
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Schering-Plough Announces Hepatitis C Data Presentations at Digestive Disease Week (DDW) 2007 Annual Meeting
2. Schering-Plough Announces Presentation of Phase II Trial Results for Novel Oral Thrombin Receptor Antagonist at the 2007 Annual Meeting of The American College of Cardiology/i2 Summit
3. New Position Statement from The North American Menopause Society Addresses Use of Local Estrogen for Treatment of Vaginal Atrophy in Postmenopausal Women
4. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
5. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
6. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
7. Pooled Studies Showed Desvenlafaxine Succinate Significantly Improved Painful Symptoms and Anxious Symptoms Associated with Major Depressive Disorder in Adults, Compared With Placebo
8. Six-Week Investigational Study In Adults With Major Depressive Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole Therapy With Antidepressants
9. Major Manufacturer of Unapproved and Adulterated Drugs
10. Exforge Helps Vast Majority of Patients Effectively Control Their Blood Pressure After Failing on Other Medicines, According to New Clinical Data
11. CuraGen and TopoTarget Announce New Clinical Results With Belinostat to be Reported at Upcoming Major Medical Meetings
Post Your Comments:
(Date:7/3/2015)... , July 4, 2015 ... cible les épidémies que sont l,hypertension, le diabète ... du Sud-Est, par l,intermédiaire de plateformes éducatives gratuites ...      (Photo: http://photos.prnewswire.com/prnh/20150630/227090 ) ... charge le diabète en ligne , Prendre ...
(Date:7/3/2015)... July 3, 2015 Un ... épidémies que sont l,hypertension, le diabète et les ... plateformes éducatives gratuites et d,une conférence majeure dédiée ... http://photos.prnewswire.com/prnh/20150630/227033 ) , Les formations ... , Prendre en charge l,hypertension en ligne ...
(Date:7/3/2015)... , July 3, 2015  Obsidian HDS, the developer ... online service for the management of data on pharmaceutical ... that PharmaShine now includes the 2014 Open Payments General ... Services on June 30. The data disclosed on Open ... between industry and providers totaling $6.49 billion and is ...
Breaking Medicine Technology:Lutter contre trois maladies chroniques majeures en Asie centrale et du Sud-Est grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Asie centrale et du Sud-Est grâce à la formation médicale 3Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 3New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2
... Cincinnati Children,s Hospital Medical Center collaborated on a 14-month ... management of teenagers with Asthma. "Mobile ... bridging knowledge to action in adolescents but there was ... as a basis for efforts to secure funding for ...
... Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR ) today ... Vice President of Research and Development, Cynthia Schwalm as ... as Senior Vice President of Pharmacovigilance. These newly created ... Company prepares for the potential launch of its lead ...
Cached Medicine Technology:GenerationOne Selected by Cincinnati Children's Hospital Medical Center for Mobile Health Pilot with Teen Asthmatics 2GenerationOne Selected by Cincinnati Children's Hospital Medical Center for Mobile Health Pilot with Teen Asthmatics 3Optimer Pharmaceuticals Expands Senior Management Team 2Optimer Pharmaceuticals Expands Senior Management Team 3Optimer Pharmaceuticals Expands Senior Management Team 4Optimer Pharmaceuticals Expands Senior Management Team 5
(Date:7/3/2015)... ... ... Bank will hopefully be getting a large donation of canned food items at the ... are making it their mission to collect as many canned items as possible. Donations do ... public as well. As part of the canned food drive, these local chiropractors will be ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... and speaker lineup for its 2015 Annual Conference , the premiere ... 2015 at the Renaissance Orlando at SeaWorld in Orlando, Florida. Speakers include ...
(Date:7/3/2015)... Kan. (PRWEB) , ... July 03, 2015 , ... ... dedicated exclusively to healthcare providers, has been retained to lead a national ... top-ranked executive search firms in the healthcare industry, B. E. Smith has recently ...
(Date:7/3/2015)... ... July 03, 2015 , ... Smoothies are all the ... good blender and easily accessible, quality ingredients. Aurora Natural is proud to introduce a ... added boost of fiber, protein, antioxidants, vitamins and minerals! , Aurora is offering a ...
(Date:7/3/2015)... ... July 03, 2015 , ... First Choice Emergency Room , the ... Manzanares, MD as the new Medical Director of its Frisco facility. , “We are ... Frisco facility,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
Breaking Medicine News(10 mins):Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 2Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 3Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3
... Customers Come From?, Enables Public To Give And ... ... Do Customers Come,From?, the new Internet marketing book by successful New Jersey,entrepreneur ... for its timely content and the author,s generous charitable campaign,Billy Gives Back,. ...
... STAAR Surgical,Company (Nasdaq: STAA ) today announced ... quarter ended September 29, 2007 on Tuesday, October,30, ... host a conference call,and webcast on Tuesday, October ... the Company,s third quarter and current corporate developments. ...
... . , A team of researchers from the ... University of Murcia, has developed a visual aid device ... especially those suffering from pathologies with a slow progression ... Degeneration, cataracts, etc.). This platform, called SERBA (in Spanish, ...
... as breakbone fever because of the excruciating back and joint ... health threat for people living in tropical countries, as well ... Rico, according to research being presented at the annual meeting ... Nov. 4-7. , Protocol Needed to Screen Blood ...
... FRESNO, Calif., Oct. 16 Almost 40% of ... food supply has,decreased over the past twelve months, according ... The registered dieticians and nutritionists also indicated a strong,preference ... with a,choice, they prefer food that was produced in ...
... Herley Industries,Inc. (Nasdaq: HRLY ) announced ... has been awarded a contract valued at,approximately $5 ... will produce high power amplifiers for EDO,s CVRJ ... and CEO, commented, "EDO has recently,announced awards with ...
Cached Medicine News:Health News:New Jersey Entrepreneur Turns a Page for Four National Charities 2Health News:STAAR Surgical Announces Third Quarter 2007 Earnings Release Date and Conference Call 2Health News:Computer simulator allows visually-impaired to drive 2Health News:Computer simulator allows visually-impaired to drive 3Health News:Substantial costs and underreporting of dengue fever, concerns about blood supply face US 2Health News:Dieticians & Nutritionists Report Decreased Confidence in Food Supply 2Health News:Herley Industries, Inc. Receives a $5 Million Award from EDO for Electronic Components for IEDs 2
... The Gemini is the newest addition ... With two distinct wavelengths to choose from, ... stands out in an exploding non-invasive aesthetic ... versatility, speed and effectiveness while maintaining the ...
... The 800 Series KTP/YAG™ Surgical Laser ... market. It is a high-power, dual-wavelength ... plastic surgery, orthopedics, general surgery, neurosurgery, ... KTP/532™ beam surgically cuts, vaporizes and ...
... D 980 nm diode laser provides controlled ... for most surgical procedures. Unlike other ... without collateral tissue damage or charring. ... instantly and seals small blood vessels ...
... a monoclonal antibody based coagglutination ... identification of Neisseria gonorrhoeae. The ... viable or fresh cultures. After ... minute rotation, a positive reaction ...
Medicine Products: